GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) released its earnings data on Wednesday. The company reported $0.65 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.71 by $0.06, Analyst Ratings Network.
As the FTSE 100 bounces around all-time highs, it's becoming difficult for investors to find attractively priced shares. However, two of the FTSE 100′s largest constituents, HSBC (LSE: HSBA) (NYSE: HSBC.
Codexis, Inc. (CDXS) announced after hours yesterday that it has signed an agreement with GlaxoSmithKline plc (GSK) that allows the latter to use its exclusive Code-Evolver� protein engineering platform technology.
Director Deals - GlaxoSmithKline PLC (GSK). 14 July 2014 | 17:40pm. StockMarketWire.com - Andrew Witty, Chief Executive Officer, has re-invested 1,790 shares in the company on the 10th July 2014 at a price of 1556.00p.